BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from Proactive to share news the company has put out updated guidance for 2022. Sobel telling Proactive the Company is estimating 2022 revenue to be between 5 and 7million which represents a significant growth of 2.5 to 3.5 times over 2021. Sobel says that guidance will be focused on how quickly its new 20 Ton/year facility is completed, and regulatory timelines influencing the conversion of the existing 2 Tons/year facility from VINIA to the production of Cannabis.
BioHarvest Sciences releases revenue guidance looking for a big jump over 2021
